Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183170 · ClinicalTrials.gov registry record · Phase 2
Residual Effects of Intoxication on Student Performance
A Phase 2 study of Neurobehavioral Manifestations and Alcoholic Intoxication, sponsored by Boston University.
- Completed
- Registry status
- Phase 2
- Development phase
- 239
- Enrollment target
- 1
- Study location
NCT00183170: Completed Phase 2 study of Neurobehavioral Manifestations and Alcoholic Intoxication, sponsored by Boston University.
NCT00183170 is a Phase 2 study of Neurobehavioral Manifestations and Alcoholic Intoxication that has completed, run by Boston University. The registered enrollment target is 239 participants, below the 687-participant average among 5 other Neurobehavioral Manifestations trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00183170, a Phase 2 study of Neurobehavioral Manifestations and Alcoholic Intoxication, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 239 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of the study is to assess the residual effects of heavy drinking on academic performance. The investigators will also explore whether these effects differ by family history of alcohol abuse and hangover symptoms, as well as compare males and females with respect to these effects. The primary hypothesis is that intoxication (0.10 g% blood alcohol concentration \[BAC\]) with an alcoholic beverage impairs next-day academic performance, as measured by scores on quizzes, standardized academic achievement tests, and standardized neurobehavioral assessments. The secondary hypothesis is that family-history-positive individuals will show a greater performance decrement the day after heavy drinking than family-history-negative individuals.
Primary Outcome
This outcome will be measured by the afternoon total mood disturbance score. This is part of the Profile of Mood States Questionnaire (POMS). POMS is a 35 item instrument with Likert responses from 0 to 4 where 0=not at all and 4=extremely. Range of scores can be 0 to 140, lower scores are more favorable.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Alcohol
Study Locations (1)
Massachusetts
- General Clinical Research Center/Boston University School of Public Health - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2004-02 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
What the finished NCT00183170 record still lists
NCT00183170 is an interventional study that assigns participants to a tested intervention. The registered 239 participants enrollment target is mid-sized for trials with a published cap, below the 687-participant average among 5 other Neurobehavioral Manifestations trials with a reported enrollment target (65% lower).
The record links to 2 conditions, with Neurobehavioral Manifestations appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00183170 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00183170 about?
NCT00183170 is a clinical study titled "Residual Effects of Intoxication on Student Performance". The primary goal of the study is to assess the residual effects of heavy drinking on academic performance. The investigators will also explore whether these effects differ by family history of alcohol abuse and hangover symptoms, as well as compare males and females with respect to these effects. Th...
What is the current status of trial NCT00183170?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 239 participants. The study started on 2004-02. Estimated completion is 2009-01.
What conditions does trial NCT00183170 study?
This clinical trial studies the following conditions: Neurobehavioral Manifestations, Alcoholic Intoxication.
What interventions are being tested in trial NCT00183170?
The interventions under investigation include: Placebo (OTHER), Alcohol (DRUG).
Who is sponsoring clinical trial NCT00183170?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00183170 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurobehavioral Manifestations
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hangover, Congeners, Sleep and Occupational Performance
COMPLETED · Phase 2
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Training Cognitive Control Processes in Older Adults
COMPLETED · NA
-
Acute and Residual Effects of Caffeinated Beer
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia